NEW

Private Company Data

Track valuations, funding rounds, and more before IPO.

Healthcare
This sector includes biotechnology, pharmaceuticals, research services, home healthcare, hospitals, long-term-care facilities, and medical equipment and supplies. Also include pharmaceutical retailers and companies which provide health information services. Companies in this sector include AstraZeneca, Pfizer, and Roche Holding, Walgreens Boots Alliance, and Cerner Corp.
Market Cap
6.519T
Market Weight
10.39%
Industries
11
Companies
1218
Healthcare S&P 500 ^GSPC
Loading Chart for Healthcare

Day Return

Sector
0.31%
S&P 500
1.71%

YTD Return

Sector
3.23%
S&P 500
5.26%

1-Year Return

Sector
4.29%
S&P 500
6.63%

3-Year Return

Sector
0.45%
S&P 500
23.18%

5-Year Return

Sector
70.13%
S&P 500
113.06%

Note: Sector performance is calculated based on the previous closing price of all sector constituents

Industries in This Sector

Select an Industry for a Visual Breakdown

IndustryMarket WeightYTD Return
All Industries
100.00%
3.23%
Drug Manufacturers - General
35.47%
7.34%
Medical Devices
13.30%
5.14%
Healthcare Plans
12.84%
8.82%
Biotechnology
10.53%
-1.98%
Diagnostics & Research
9.87%
-8.18%
Medical Instruments & Supplies
7.25%
-6.77%
Medical Care Facilities
2.95%
5.89%
Medical Distribution
2.80%
15.63%
Drug Manufacturers - Specialty & Generic
2.57%
-0.97%
Health Information Services
2.27%
3.94%
Pharmaceutical Retailers
0.16%
19.65%

Note: Percentage % data on heatmap indicates Day Return

All Industries

Drug Manufacturers - General
0.57%
Medical Devices
-0.74%
Healthcare Plans
0.36%
Biotechnology
-0.80%
Diagnostics & Research
-1.57%
Medical Instruments & Supplies
-1.94%
Medical Care Facilities
-0.43%
Medical Distribution
0.03%
Drug Manufacturers - Specialty & Generic
-0.96%
Health Information Services
-1.60%
Pharmaceutical Retailers
-0.10%

<= -3

-2

-1

0

1

2

>= 3

Largest Companies in This Sector

View More
Table View
Heatmap View
Name
Last Price
1Y Target Est.
Market Weight
Market Cap
Day Change %
YTD Return
Avg. Analyst Rating
824.97 1,010.47 11.56% 741.909B +0.39% +6.85%
Buy
519.34 628.03 7.45% 477.944B +0.70% +2.67%
Strong Buy
164.03 169.06 6.15% 394.934B +0.55% +13.42%
Buy
204.41 211.73 5.63% 361.221B +0.83% +15.03%
Buy
131.46 136.68 3.55% 228.003B +0.08% +16.22%
Buy
89.44 112.07 3.52% 226.238B +2.08% -10.11%
Buy
503.47 659.08 3.00% 192.577B -1.60% -3.22%
Buy
492.94 624.78 2.74% 175.573B -2.95% -5.56%
Buy
307.52 315.95 2.58% 165.302B +0.57% +17.99%
Buy
206.80 266.23 2.33% 149.366B -1.43% -9.91%
Buy

Investing in the Healthcare Sector

Start Investing in the Healthcare Sector Through These ETFs and Mutual Funds

ETF Opportunities

View More
Name
Last Price
Net Assets
Expense Ratio
YTD Return
144.94 39.256B 0.08% +5.35%
263.58 19.81B 0.09% +3.90%
130.74 6.317B 0.45% -1.11%
84.65 5.908B 0.35% -6.01%
59.58 5.032B 0.40% +2.12%

Mutual Fund Opportunities

View More
Name
Last Price
Net Assets
Expense Ratio
YTD Return
185.05 40.882B 0.30% +1.47%
78.03 40.882B 0.30% +1.48%
132.14 19.81B 0.09% +4.14%
80.61 13.1B 0.80% +1.13%
80.39 13.1B 0.80% +1.08%

Healthcare Research

View More

Discover the Latest Analyst and Technical Research for This Sector

  • The Argus Mid-Cap Model Portfolio

    Despite bursts of outperformance, small- and mid-cap stocks (SMID) have underperformed large-caps year to date -- as they have over the past five years. But they may be in a better position to generate market-beating returns going forward. For one thing, SMID companies tend to focus on domestic markets, so their businesses could be less disrupted by the trade and tariff debate, or fallout from unrest in the Middle East, the Russian invasion of Ukraine, issues in China, or other geopolitical developments. As well, the prices of SMID stocks generally are lower than the prices of large-caps. Finally, there are long stretches in the record books when SMID stocks have outperformed large-caps. SMID stocks can be risky, but despite those risks, diversified investors look to have exposure to small- and mid-caps based on the long-term performance record. We estimate that 20% of the U.S. stock market's capitalization is comprised of SMID stocks.

     
  • Daily Spotlight: Fed's Favorite Inflation Indicator Out Today

    The Fed's favorite inflation indicator, the PCE Price Index, will be released by the BEA this morning. The index differs from the better-known Consumer Price Index as its composition is changed more frequently and it is quicker to reflect real-time pricing fluctuations. In the January report, PCE inflation grew 2.5% year over year. The latest CPI report (February) had inflation rising 2.8%. Core PCE, which removes volatile food and energy prices, rose at a rate of 2.6% in the latest month. Our PCE forecasts call for steady-to-lower readings for February: 2.4% for the headline number and for 2.6% for the core reading, as lingering inflation in certain sticky-priced services remains a challenge. Overall, inflation in this cycle peaked in summer 2022 and has been on a fairly consistent downward trek since then. We track 20 inflation measures on a monthly basis. On average, they are indicating that prices are rising at a 3.15% rate year over year, essentially flat with a month ago. The numbers are volatile and are distorted by swings within the volatile Producer Price Inflation report. Focusing on core inflation - which we obtain by averaging Core CPI, market-based PCE Ex-Food & Energy, the five-year forward inflation expectation rate, the 10-year TIPs Break-even Interest Rate, and the core PCE Price Index - our reading is 2.60%, lower by five basis points month over month. Investors are expecting that the Fed's series of rate hikes ultimately will tame inflation, with the five-year forward expectation rate at 2.15%. Given inflation trends, we expect the Fed to remain on the sideline for the first half of 2025 and then implement two rate cuts in 2H24, with the ultimate goal of aligning the fed funds rate to approximately 100 basis points above the long-term inflation rate within the next 8-10 quarters.

     
  • Daily – Vickers Top Buyers & Sellers for 03/28/2025

    The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.

     
  • Daily – Vickers Top Insider Picks for 03/28/2025

    The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.

     

From the Community

Healthcare News